NHRI · NYCU · NCHU · NUU
Anchoring national research leadership at NHRI while integrating universities, hospitals, and industry around clinically consequential biomedical engineering.
Professor Liao builds strategic partnerships across Taiwan, Singapore, Japan, the United States, and Malaysia—linking national research institutes, leading universities, hospitals, and international scientific communities to advance neuroengineering, biomedical imaging, intelligent medical devices, and clinical translation.
Anchoring national research leadership at NHRI while integrating universities, hospitals, and industry around clinically consequential biomedical engineering.
Extending long-standing scientific leadership in Singapore across neurophotonics, neurotechnology, and the wider Asia-Pacific research community.
Deepening research ties with the University of Maryland and Johns Hopkins University across neuroengineering, biomedical imaging, and clinical science.
Leading the University of Tokyo–NHRI bilateral platform to advance strategic Japan–Taiwan collaboration in biomedical engineering, brain science, and clinical translation.
Expanding Southeast Asian collaboration in biomedical engineering, intelligent sensing, and translational research while strengthening regional networks and talent exchange.
Building multi-institutional alliances that unite neuroengineering, biomedical imaging, intelligent sensing, and clinical expertise to address consequential biomedical questions and accelerate translation.
Convening bilateral symposia and international forums—including the University of Tokyo–NHRI platform—to shape dialogue and collaboration at the frontiers of brain science, AI, and biomedical engineering.
Creating sustained pathways for emerging investigators to work across world-class platforms, interdisciplinary mentorship networks, and co-led research spanning Taiwan, Singapore, Japan, the United States, and Malaysia.
Particularly across neuroimaging, intelligent medical devices, artificial intelligence and digital health, clinical validation, and cross-border research in Asia.
Start a conversation →